Newman Dignan & Sheerar, Inc. Merck & Co., Inc. Transaction History
Newman Dignan & Sheerar, Inc.
- $429 Million
- Q2 2025
A detailed history of Newman Dignan & Sheerar, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Newman Dignan & Sheerar, Inc. holds 45,934 shares of MRK stock, worth $3.65 Million. This represents 0.85% of its overall portfolio holdings.
Number of Shares
45,934
Previous 46,985
2.24%
Holding current value
$3.65 Million
Previous $4.22 Million
13.78%
% of portfolio
0.85%
Previous 1.16%
Shares
33 transactions
Others Institutions Holding MRK
# of Institutions
3,874Shares Held
1.92BCall Options Held
25.7MPut Options Held
24.2M-
Vanguard Group Inc Valley Forge, PA253MShares$20.1 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY207MShares$16.5 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$9.57 Billion0.46% of portfolio
-
Wellington Management Group LLP Boston, MA81.7MShares$6.49 Billion1.46% of portfolio
-
Geode Capital Management, LLC Boston, MA59.7MShares$4.74 Billion0.43% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $201B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...